Lacktman, Chmielewski Discuss Foley’s 2017 Telemedicine and Digital Health Survey Results
15 November 2017
Partners Nate Lacktman and Monica Chmielewski were quoted in an mHealthIntelligence article, “New Survey Takes Telemedicine Beyond Pilots, Into Growth Phase,” about the findings of Foley’s 2017 Telemedicine and Digital Health Survey.
From a previously written analysis about the survey, mHealthIntelligence included Lacktman’s commentary: “[T]he industry outlook has changed dramatically, due in large part to proven patient outcomes and surging demand among providers looking to improve the quality of care in a more convenient, cost-effective manner.”
He also stated that “too many providers and entrepreneurs are overwhelmed and confused with the myriad legal and regulatory issues when delivering healthcare services through technology and across states. They want expert advisors who can offer solutions and legally compliant pathways to success across states, not simply to tell them whether or not an in-person exam is required.”
Chmielewski explained, “There’s no reason to deny reimbursement or pay less for telemedicine-based services simply because it is delivered through new technology. Third-party reimbursement needs to catch up, and Congress needs to change the rules for Medicare.”
From a previously written analysis about the survey, mHealthIntelligence included Lacktman’s commentary: “[T]he industry outlook has changed dramatically, due in large part to proven patient outcomes and surging demand among providers looking to improve the quality of care in a more convenient, cost-effective manner.”
He also stated that “too many providers and entrepreneurs are overwhelmed and confused with the myriad legal and regulatory issues when delivering healthcare services through technology and across states. They want expert advisors who can offer solutions and legally compliant pathways to success across states, not simply to tell them whether or not an in-person exam is required.”
Chmielewski explained, “There’s no reason to deny reimbursement or pay less for telemedicine-based services simply because it is delivered through new technology. Third-party reimbursement needs to catch up, and Congress needs to change the rules for Medicare.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”